JP Morgan Chase
BGMD

JP Morgan Chase’s BG MEDICINE INC COM STK NEW BGMD Stock Holding History

JP Morgan Chase’s Portfolio BGMD Stock Details BGMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-4,684
Closed -$25K – 4541
2013
Q2 		$25K Buy
+4,684
New +$31.2K ﹤0.01% 4321

Other funds holding BGMD

GE
General Electric Evendale, Ohio $308M AUM 40.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
MVP
Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return
CLM
ClearBridge LLC (Maryland) Baltimore, Maryland $329M AUM 9.73% 1-Year Est. Return
VFS
VSR Financial Services Overland Park, Kansas $607M AUM 0.85% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JP Morgan Chase's BGMD Position: Q3 2013 in Review

JP Morgan Chase sold out of BG MEDICINE INC COM STK NEW (BGMD) in Q3 2013, closing a stake of 4,684 shares — an estimated $25K sold.

JP Morgan Chase first reported a position in BGMD in Q2 2013 and held it in 1 quarter. The position peaked at $25K in Q2 2013. 23 funds tracked by Wall St. Rank hold BGMD as of Q3 2013.

  • JP Morgan Chase reported no remaining BG MEDICINE INC COM STK NEW position as of Q3 2013 after selling out during the quarter.
  • JP Morgan Chase sold 4,684 BG MEDICINE INC COM STK NEW shares in Q3 2013, an estimated $25K.
  • JP Morgan Chase first reported a position in BG MEDICINE INC COM STK NEW in Q2 2013 and held it in 1 quarter.
  • JP Morgan Chase's BG MEDICINE INC COM STK NEW position peaked at $25K in Q2 2013.
  • 23 funds tracked by Wall St. Rank held BG MEDICINE INC COM STK NEW as of Q3 2013.

Based on JP Morgan Chase's 13F filing for Q3 2013, filed 31 Oct 2013.